Skip to main content
. Author manuscript; available in PMC: 2017 Feb 15.
Published in final edited form as: Biol Psychiatry. 2015 Apr 2;79(4):266–273. doi: 10.1016/j.biopsych.2015.03.025

Table 1.

Clinical outcome measurements in each group (pre and post-treatment).

Items tVNS group stVNS group
pre-treatment Post-treatment pre-treatment Post-treatment
HAMD* 28.50±6.42 15.00±4.59 28.56±4.79 23.00±4.68
HAMA 19.61±5.88 11.67±7.06 16.88±4.19 13.44±3.71
SAS score* 56.56±8.69 42.83±10.90 58.50±10.71 54.44±5.72
SDS score* 66.33±11.11 50.56±12.05 66.94±9.28 61.19±10.02
*

indicates significant difference in pre- and post-treatment changes (P< 0.05) using repeated measurements after adjusting for age and gender.